Other
BPI
BPI is an intervention with 4 clinical trials. Historical success rate of 33.3%.
Total Trials
4
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
2(50%)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
33.3%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
completed125%
not_yet_recruiting125%
terminated250%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Erector Spinae Plane Block for Chronic Pain After Spinal Surgery
NCT07834502
completed
Comparative Study of Personality in Parkinson's Disease Patients With Other Chronic Pain
NCT05713500
terminated
Cognitive Changes With Gabapentin Treatment
NCT04106011
terminatedphase_2
Pharmacokinetic Response to BPI in Burns
NCT00462904
Clinical Trials (4)
Showing 4 of 4 trials
NCT07834502Not Applicable
Erector Spinae Plane Block for Chronic Pain After Spinal Surgery
NCT05713500
Comparative Study of Personality in Parkinson's Disease Patients With Other Chronic Pain
NCT04106011
Cognitive Changes With Gabapentin Treatment
NCT00462904Phase 2
Pharmacokinetic Response to BPI in Burns
All 4 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 4